SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-371935
Filing Date
2015-11-09
Accepted
2015-11-09 16:11:10
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d10795d10q.htm 10-Q 320588
2 EX-31.1 d10795dex311.htm EX-31.1 8392
3 EX-31.2 d10795dex312.htm EX-31.2 8377
4 EX-32.1 d10795dex321.htm EX-32.1 3673
5 EX-32.2 d10795dex322.htm EX-32.2 3564
  Complete submission text file 0001193125-15-371935.txt   2562654

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20150930.xml EX-101.INS 430114
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20150930.xsd EX-101.SCH 37173
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20150930_cal.xml EX-101.CAL 47539
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20150930_def.xml EX-101.DEF 107802
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20150930_lab.xml EX-101.LAB 283629
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20150930_pre.xml EX-101.PRE 196990
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 151215710
SIC: 2834 Pharmaceutical Preparations